← Back to All US Stocks

Precision Optics Corporation, Inc.. (POCI) Stock Fundamental Analysis & AI Rating 2026

POCI Nasdaq Electromedical & Electrotherapeutic Apparatus MA CIK: 0000867840
Recently Updated • Analysis: Apr 14, 2026 • SEC Data: 2025-12-31
STRONG SELL
92% Conf
Pending
Analysis scheduled

📊 POCI Key Takeaways

Revenue: $14.0M
Net Margin: -24.3%
Free Cash Flow: $-405.1K
Current Ratio: 1.05x
Debt/Equity: 0.17x
EPS: $-0.44
AI Rating: STRONG SELL with 92% confidence
Precision Optics Corporation, Inc.. (POCI) receives a STRONG SELL rating with 92% confidence from our AI fundamental analysis based on SEC 10-K filings. With revenue of $14.0M, net profit margin of -24.3%, and return on equity (ROE) of -36.6%, Precision Optics Corporation, Inc.. demonstrates mixed fundamentals in the Healthcare sector. Below is our complete POCI stock analysis for 2026.

Is Precision Optics Corporation, Inc.. (POCI) a Good Investment?

Claude

Precision Optics is in severe financial distress with accelerating losses (-24.3% net margin), negative operating cash flow, and dangerously low liquidity (quick ratio 0.62x). The company is burning cash at $405K annually with only $881K in reserves, leaving minimal runway. Flat revenue growth combined with collapsing profitability signals fundamental operational failure with no visible turnaround.

Why Buy Precision Optics Corporation, Inc.. Stock? POCI Key Strengths

Claude
  • + Conservative leverage with debt-to-equity ratio of only 0.17x limits financial risk from debt burden
  • + Positive stockholders' equity of $9.3M provides some cushion, though rapidly eroding
  • + Recent insider trading activity suggests some stakeholder engagement with the business

POCI Stock Risks: Precision Optics Corporation, Inc.. Investment Risks

Claude
  • ! Critical liquidity crisis: quick ratio of 0.62x cannot cover current liabilities; only $881.5K cash with negative operating cash flow
  • ! Profitability collapse across all metrics (net margin -24.3%, operating margin -23.8%, ROE -36.6%, ROA -14.9%) with EPS declining 73.5% YoY
  • ! Structural cost problems evident in 8.2% gross margin, indicating non-competitive pricing, high COGS, or market rejection
  • ! Stagnant revenue (-0.1% YoY) combined with free cash flow burn of $405.1K annualizes to potential cash depletion within 2-3 years
  • ! Negative interest coverage ratio (-41.6x) indicates inability to service debt from operations

Key Metrics to Watch

Claude
  • * Operating cash flow trend - must return to positive to indicate business sustainability
  • * Gross margin improvement - currently at crisis levels; any pickup would suggest operational turnaround
  • * Cash burn rate and cash position runway - critical for survival timeline
  • * Revenue growth acceleration - current flat growth provides no positive momentum
  • * Cost structure reduction path - need evidence of margin expansion initiatives

Precision Optics Corporation, Inc.. (POCI) Financial Metrics & Key Ratios

Revenue
$14.0M
Net Income
$-3.4M
EPS (Diluted)
$-0.44
Free Cash Flow
$-405.1K
Total Assets
$22.9M
Cash Position
$881.5K

💡 AI Analyst Insight

Precision Optics Corporation, Inc.. presents a mixed fundamental picture. Review the detailed metrics above to form your own investment thesis.

POCI Profit Margin, ROE & Profitability Analysis

Gross Margin 8.2%
Operating Margin -23.8%
Net Margin -24.3%
ROE -36.6%
ROA -14.9%
FCF Margin -2.9%

POCI vs Healthcare Sector: How Precision Optics Corporation, Inc.. Compares

How Precision Optics Corporation, Inc.. compares to Healthcare sector averages

Net Margin
POCI -24.3%
vs
Sector Avg 12.0%
POCI Sector
ROE
POCI -36.6%
vs
Sector Avg 15.0%
POCI Sector
Current Ratio
POCI 1.0x
vs
Sector Avg 2.0x
POCI Sector
Debt/Equity
POCI 0.2x
vs
Sector Avg 0.6x
POCI Sector

Sector benchmarks are approximate industry averages. Actual sector performance may vary.

Is Precision Optics Corporation, Inc.. Stock Overvalued? POCI Valuation Analysis 2026

Based on fundamental analysis, Precision Optics Corporation, Inc.. has mixed fundamental signals relative to the Healthcare sector in 2026.

Return on Equity
-36.6%
Sector avg: 15%
Net Profit Margin
-24.3%
Sector avg: 12%
Revenue Growth
N/A
Year-over-year
Debt/Equity
0.17x
Sector avg: 0.6x

Note: This is a fundamental analysis based on SEC filings. For P/E ratio, price targets, and market-based valuation, consult financial data providers. This is not investment advice.

Precision Optics Corporation, Inc.. Balance Sheet: POCI Debt, Cash & Liquidity

Current Ratio
1.05x
Quick Ratio
0.62x
Debt/Equity
0.17x
Debt/Assets
59.3%
Interest Coverage
-41.60x
Long-term Debt
$1.6M

POCI Revenue & Earnings Growth: 5-Year Financial Trend

POCI 5-year financial data: Year 2021: Revenue $10.7M, Net Income -$1.4M, EPS N/A. Year 2022: Revenue $15.7M, Net Income -$102.8K, EPS $-0.01. Year 2023: Revenue $21.0M, Net Income -$928.4K, EPS $-0.18. Year 2024: Revenue $21.0M, Net Income -$144.6K, EPS $-0.03. Year 2025: Revenue $19.1M, Net Income -$3.0M, EPS $-0.49.
Revenue
Net Income
EPS (right axis)

5-Year Trend Summary: Precision Optics Corporation, Inc..'s revenue has grown significantly by 79% over the 5-year period, indicating strong business expansion. The most recent EPS of $-0.49 indicates the company is currently unprofitable.

POCI Revenue Growth, EPS Growth & YoY Performance

Revenue Growth
N/A
Year-over-year
Net Income Growth
N/A
Year-over-year
EPS Growth
N/A
Earnings per share
FCF Margin
-2.9%
Free cash flow / Revenue

POCI Quarterly Earnings & Performance

Quarterly financial performance data for Precision Optics Corporation, Inc.. including revenue, net income, and earnings per share.
Quarter Revenue Net Income EPS
Q2 2026 $4.5M -$969.7K $-0.15
Q1 2026 $4.2M -$1.3M $-0.21
Q3 2025 $4.2M -$317.1K $-0.05
Q2 2025 $4.5M -$464.4K $-0.13
Q1 2025 $4.2M -$464.4K $-0.08
Q3 2024 $5.0M -$48.5K $-0.01
Q2 2024 $4.8M -$158.7K $0.06
Q1 2024 $4.3M -$158.7K $-0.03

Data sourced from SEC EDGAR 10-Q quarterly filings. Figures may represent quarterly or cumulative values.

Precision Optics Corporation, Inc.. Dividends, Buybacks & Capital Allocation

Operating Cash Flow
-$177.9K
Cash generated from operations
Capital Expenditures
$227.2K
Investment in assets
Dividends
None
No dividend program

POCI SEC Filings: Latest 10-K & 10-Q Analysis

Access official SEC EDGAR filings for Precision Optics Corporation, Inc.. (CIK: 0000867840)

📋 Recent SEC Filings

Date Form Document Action
Apr 2, 2026 4 xslF345X06/ownership.xml View →
Apr 1, 2026 4 xslF345X06/ownership.xml View →
Apr 1, 2026 4 xslF345X06/ownership.xml View →
Apr 1, 2026 4 xslF345X06/ownership.xml View →
Mar 30, 2026 8-K poci_8k.htm View →

Frequently Asked Questions about POCI

What is the AI rating for POCI?

Precision Optics Corporation, Inc.. (POCI) has an AI rating of STRONG SELL with 92% confidence, based on fundamental analysis of SEC EDGAR filings.

What are POCI's key strengths?

Claude: Conservative leverage with debt-to-equity ratio of only 0.17x limits financial risk from debt burden. Positive stockholders' equity of $9.3M provides some cushion, though rapidly eroding.

What are the risks of investing in POCI?

Claude: Critical liquidity crisis: quick ratio of 0.62x cannot cover current liabilities; only $881.5K cash with negative operating cash flow. Profitability collapse across all metrics (net margin -24.3%, operating margin -23.8%, ROE -36.6%, ROA -14.9%) with EPS declining 73.5% YoY.

What is POCI's revenue and growth?

Precision Optics Corporation, Inc.. reported revenue of $14.0M.

Does POCI pay dividends?

Precision Optics Corporation, Inc.. does not currently pay dividends.

Where can I find POCI SEC filings?

Official SEC filings for Precision Optics Corporation, Inc.. (CIK: 0000867840) including 10-K, 10-Q, and 8-K reports are available on SEC EDGAR.

What is POCI's EPS?

Precision Optics Corporation, Inc.. has a diluted EPS of $-0.44.

How is the AI analysis conducted?

Two independent AI systems — Claude (Anthropic) and ChatGPT (OpenAI) — analyze SEC EDGAR filings including 10-K annual reports and 10-Q quarterly reports. Each AI evaluates financial health, profitability ratios, balance sheet strength, and growth metrics. The combined rating reflects both perspectives for balanced insights.

Is POCI a good stock to buy right now?

Based on our AI fundamental analysis in April 2026, Precision Optics Corporation, Inc.. has a STRONG SELL rating with 92% confidence. Review the strengths and risks sections above before making a decision. This is not investment advice.

Is POCI stock overvalued or undervalued?

Valuation metrics for POCI: ROE of -36.6% (sector avg: 15%), net margin of -24.3% (sector avg: 12%). Compare these metrics with sector averages to assess valuation.

Should I buy POCI stock in 2026?

Our dual AI analysis gives Precision Optics Corporation, Inc.. a combined STRONG SELL rating for 2026. Revenue is data pending, with profitability at or below sector average. Always conduct your own research.

What is POCI's free cash flow?

Precision Optics Corporation, Inc..'s operating cash flow is $-177.9K, with capital expenditures of $227.2K. FCF margin is -2.9%.

How does POCI compare to other Healthcare stocks?

Vs Healthcare sector averages: Net margin -24.3% (avg: 12%), ROE -36.6% (avg: 15%), current ratio 1.05 (avg: 2).

Top Rated Stocks
NSSC 92% MLI 92% MELI 92% MDXG 92% MANH 92% INVA 92% GGG 92% GCT 92% FTNT 92% FSLR 92%
Sector: All Healthcare Stocks →
Disclaimer: This analysis is generated by Claude AI (Anthropic) and ChatGPT (OpenAI) based on publicly available SEC EDGAR filings. It does not include stock price data and should not be considered financial advice. All fundamental data is sourced from SEC public domain filings. Always conduct your own research and consult with a qualified financial advisor before making investment decisions.
Data Source: SEC EDGAR | Analysis Date: Apr 14, 2026 | Data as of: 2025-12-31 | Powered by Claude AI